1 min read
Amanda Humphrey: May 19, 2025
With U.S. healthcare costs projected to rise by up to 8% in 2025, employers are facing a new challenge: how to manage the growing cost of GLP-1 medications like Ozempic®, Wegovy® and Mounjaro®. Originally approved to treat Type 2 diabetes, these...
Read More
1 min read
Amanda Humphrey: May 19, 2025
Welcome to the May edition of Benefits Buzz! In this monthly issue, we dive into the latest topics related to employee benefits, wellness programs...
1 min read
Ryan McWalter: May 6, 2025
A shaky start amid tariffs and global uncertainty After two strong years for U.S. markets, 2025 kicked off with turbulence. What began as a promising...
Amanda Humphrey: April 4, 2025
Is your organization at risk?
1 min read
Amanda Humphrey: April 4, 2025
This month's highlights Topic #1: Class-action lawsuits target health plan tobacco surcharges. Topic #2: IRS issues ACA reporting guidance on...
Amanda Humphrey: April 4, 2025
With more than 150 voluntary benefits available to supplement traditional offerings like health insurance and 401(k) plans, choosing the right mix...
Amanda Humphrey: April 4, 2025
What it means for employers and patients On Feb. 25, President Donald Trump issued an executive order aimed at improving healthcare price...
1 min read
Amanda Humphrey: March 17, 2025
Welcome to the March 2025 edition of Benefits Buzz! In this month's issue, we explore the latest developments in employee benefits, workplace...
1 min read
Amanda Humphrey: March 17, 2025
Wondering how HDHP changes impact your organization? The recent updates to high deductible health plans (HDHPs) for 2025 bring crucial adjustments...
